company string | company_tickers list | cik string | sic string | office string | industry string | exchanges list | filing_type string | filing_date string | filing_accession_number string | filing_processed bool | parsed_toc_keys string | parsed_prospectus_summary_valid bool | parsed_prospectus_summary string | parsed_prospectus_summary_word_count int64 | parsed_risk_factors_valid bool | parsed_risk_factors string | parsed_risk_factors_word_count int64 | parsed_legal_matters_valid bool | parsed_legal_matters string | parsed_legal_matters_word_count int64 | filing_url string | filing_images list |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GRI Bio, Inc. | [
"GRI"
] | 0001824293 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2022-05-27 00:00:00 | 0001628280-22-015651 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001824293/000162828022015651/vallons-1warrantshares.htm | [] |
GRI Bio, Inc. | [
"GRI"
] | 0001824293 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2021-01-28 00:00:00 | 0001104659-21-008880 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001824293/000110465921008880/tm2030737-9_s1a.htm | [] |
GRI Bio, Inc. | [
"GRI"
] | 0001824293 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2021-01-14 00:00:00 | 0001104659-21-003928 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001824293/000110465921003928/tm2030737-7_s1a.htm | [] |
GRI Bio, Inc. | [
"GRI"
] | 0001824293 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2020-11-16 00:00:00 | 0001104659-20-125904 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001824293/000110465920125904/tm2030737-5_s1a.htm | [] |
GRI Bio, Inc. | [
"GRI"
] | 0001824293 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2020-10-23 00:00:00 | 0001104659-20-117717 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001824293/000110465920117717/tm2030737-1_s1.htm | [] |
Onfolio Holdings, Inc | [
"ONFOP"
] | 0001825452 | 7374 | 06 Technology | Services-Computer Processing & Data Preparation | [
"Nasdaq",
"OTC"
] | S-1/A | 2026-01-28 00:00:00 | 0001654954-26-000655 | true | ABOUT THIS PROSPECTUS; PROSPECTUS SUMMARY; THE OFFERING; RISK FACTORS; CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS; USE OF PROCEEDS; DIVIDEND POLICY; DETERMINATION OF OFFERING PRICE; BUSINESS; SELLING STOCKHOLDER; DESCRIPTION OF SECURITIES; PLAN OF DISTRIBUTION; LEGAL MATTERS; EXPERTS; INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE; WHERE YOU CAN FIND MORE INFORMATION | false | ./parsed_sections/prospectus_summary/2026/ONFOP_onfolio_prospectus_summary.txt | 1,000 | false | ./parsed_sections/risk_factors/2025/ONFOP_onfolio_risk_factors.txt | 44,193 | false | ./parsed_sections/legal_matters/2026/ONFOP_onfolio_legal_matters.txt | 336 | https://www.sec.gov/Archives/edgar/data/0001825452/000165495426000655/onfo_s1a.htm | [
"https://www.sec.gov/Archives/edgar/data/0001825452/000165495426000655/onfo_s1aimg1.jpg"
] |
Onfolio Holdings, Inc | [
"ONFOP"
] | 0001825452 | 7374 | 06 Technology | Services-Computer Processing & Data Preparation | [
"Nasdaq",
"OTC"
] | S-1 | 2025-12-18 00:00:00 | 0001654954-25-014068 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001825452/000165495425014068/onfo_s1.htm | [] |
Onfolio Holdings, Inc | [
"ONFOP"
] | 0001825452 | 7374 | 06 Technology | Services-Computer Processing & Data Preparation | [
"Nasdaq",
"OTC"
] | S-1 | 2025-08-22 00:00:00 | 0001654954-25-009950 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001825452/000165495425009950/onfo_s1.htm | [] |
Onfolio Holdings, Inc | [
"ONFOP"
] | 0001825452 | 7374 | 06 Technology | Services-Computer Processing & Data Preparation | [
"Nasdaq",
"OTC"
] | S-1/A | 2022-08-16 00:00:00 | 0001654954-22-011469 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001825452/000165495422011469/onfolio_s1a.htm | [] |
Onfolio Holdings, Inc | [
"ONFOP"
] | 0001825452 | 7374 | 06 Technology | Services-Computer Processing & Data Preparation | [
"Nasdaq",
"OTC"
] | S-1/A | 2022-07-25 00:00:00 | 0001654954-22-009998 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001825452/000165495422009998/onfolio_s1a.htm | [] |
Onfolio Holdings, Inc | [
"ONFOP"
] | 0001825452 | 7374 | 06 Technology | Services-Computer Processing & Data Preparation | [
"Nasdaq",
"OTC"
] | S-1/A | 2022-06-14 00:00:00 | 0001654954-22-008320 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001825452/000165495422008320/onfolio_s1.htm | [] |
Onfolio Holdings, Inc | [
"ONFOP"
] | 0001825452 | 7374 | 06 Technology | Services-Computer Processing & Data Preparation | [
"Nasdaq",
"OTC"
] | S-1/A | 2022-05-13 00:00:00 | 0001654954-22-006764 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001825452/000165495422006764/onfolio_s1.htm | [] |
Onfolio Holdings, Inc | [
"ONFOP"
] | 0001825452 | 7374 | 06 Technology | Services-Computer Processing & Data Preparation | [
"Nasdaq",
"OTC"
] | S-1/A | 2022-04-26 00:00:00 | 0001654954-22-005381 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001825452/000165495422005381/onfolio_s1.htm | [] |
Onfolio Holdings, Inc | [
"ONFOP"
] | 0001825452 | 7374 | 06 Technology | Services-Computer Processing & Data Preparation | [
"Nasdaq",
"OTC"
] | S-1 | 2022-04-07 00:00:00 | 0001654954-22-004732 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001825452/000165495422004732/onfolio_s1.htm | [] |
Banzai International, Inc. | [
"BNZIW"
] | 0001826011 | 7372 | 06 Technology | Services-Prepackaged Software | [
"Nasdaq"
] | S-1 | 2025-12-09 00:00:00 | 0001493152-25-026856 | true | ABOUT THIS PROSPECTUS; CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS; PROSPECTUS SUMMARY; RISK FACTORS; USE OF PROCEEDS; MARKET INFORMATION FOR CLASS A COMMON STOCK AND DIVIDEND POLICY; MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS; BUSINESS; MANAGEMENT; EXECUTIVE AND DIRECTOR COMPENSATION; CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS; PRINCIPAL SECURITYHOLDERS; SELLING SECURITYHOLDER; PLAN OF DISTRIBUTION; DESCRIPTION OF SECURITIES; MATERIAL UNITED STATES FEDERAL INCOME TAX CONSEQUENCES; LEGAL MATTERS; EXPERTS; WHERE YOU CAN FIND MORE INFORMATION; INDEX TO FINANCIAL STATEMENTS | false | ./parsed_sections/prospectus_summary/2025/BNZIW_banzai_prospectus_summary.txt | 3 | false | ./parsed_sections/risk_factors/2025/BNZIW_banzai_risk_factors.txt | 20,416 | false | ./parsed_sections/legal_matters/2025/BNZIW_banzai_legal_matters.txt | 3,423 | https://www.sec.gov/Archives/edgar/data/0001826011/000149315225026856/forms-1.htm | [
"https://www.sec.gov/Archives/edgar/data/0001826011/000149315225026856/forms-1_001.jpg",
"https://www.sec.gov/Archives/edgar/data/0001826011/000149315225026856/audit_001.jpg",
"https://www.sec.gov/Archives/edgar/data/0001826011/000149315225026856/audit_002.jpg"
] |
Banzai International, Inc. | [
"BNZIW"
] | 0001826011 | 7372 | 06 Technology | Services-Prepackaged Software | [
"Nasdaq"
] | S-1 | 2025-09-12 00:00:00 | 0001641172-25-027249 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001826011/000164117225027249/forms-1.htm | [] |
Banzai International, Inc. | [
"BNZIW"
] | 0001826011 | 7372 | 06 Technology | Services-Prepackaged Software | [
"Nasdaq"
] | S-1 | 2024-10-16 00:00:00 | 0001493152-24-041316 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001826011/000149315224041316/forms-1.htm | [] |
Banzai International, Inc. | [
"BNZIW"
] | 0001826011 | 7372 | 06 Technology | Services-Prepackaged Software | [
"Nasdaq"
] | S-1/A | 2024-10-07 00:00:00 | 0001493152-24-040319 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001826011/000149315224040319/forms-1a.htm | [] |
Banzai International, Inc. | [
"BNZIW"
] | 0001826011 | 7372 | 06 Technology | Services-Prepackaged Software | [
"Nasdaq"
] | S-1 | 2024-10-04 00:00:00 | 0001493152-24-039516 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001826011/000149315224039516/forms-1.htm | [] |
Banzai International, Inc. | [
"BNZIW"
] | 0001826011 | 7372 | 06 Technology | Services-Prepackaged Software | [
"Nasdaq"
] | S-1/A | 2024-09-25 00:00:00 | 0001493152-24-038162 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001826011/000149315224038162/forms-1a.htm | [] |
Banzai International, Inc. | [
"BNZIW"
] | 0001826011 | 7372 | 06 Technology | Services-Prepackaged Software | [
"Nasdaq"
] | S-1 | 2024-09-24 00:00:00 | 0001493152-24-037922 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001826011/000149315224037922/forms-1.htm | [] |
Banzai International, Inc. | [
"BNZIW"
] | 0001826011 | 7372 | 06 Technology | Services-Prepackaged Software | [
"Nasdaq"
] | S-1 | 2024-09-20 00:00:00 | 0001493152-24-037198 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001826011/000149315224037198/forms-1.htm | [] |
Banzai International, Inc. | [
"BNZIW"
] | 0001826011 | 7372 | 06 Technology | Services-Prepackaged Software | [
"Nasdaq"
] | S-1 | 2024-07-31 00:00:00 | 0001493152-24-029660 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001826011/000149315224029660/forms-1.htm | [] |
Banzai International, Inc. | [
"BNZIW"
] | 0001826011 | 7372 | 06 Technology | Services-Prepackaged Software | [
"Nasdaq"
] | S-1/A | 2024-05-16 00:00:00 | 0001193125-24-140732 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001826011/000119312524140732/d821577ds1a.htm | [] |
Banzai International, Inc. | [
"BNZIW"
] | 0001826011 | 7372 | 06 Technology | Services-Prepackaged Software | [
"Nasdaq"
] | S-1 | 2024-04-22 00:00:00 | 0001193125-24-105081 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001826011/000119312524105081/d821577ds1.htm | [] |
Banzai International, Inc. | [
"BNZIW"
] | 0001826011 | 7372 | 06 Technology | Services-Prepackaged Software | [
"Nasdaq"
] | S-1/A | 2024-02-05 00:00:00 | 0001193125-24-023808 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001826011/000119312524023808/d567008ds1a.htm | [] |
Banzai International, Inc. | [
"BNZIW"
] | 0001826011 | 7372 | 06 Technology | Services-Prepackaged Software | [
"Nasdaq"
] | S-1 | 2023-12-29 00:00:00 | 0001193125-23-305583 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001826011/000119312523305583/d567008ds1.htm | [] |
Banzai International, Inc. | [
"BNZIW"
] | 0001826011 | 7372 | 06 Technology | Services-Prepackaged Software | [
"Nasdaq"
] | S-1/A | 2020-12-16 00:00:00 | 0001213900-20-043086 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001826011/000121390020043086/ea131783-s1a2_7gcholdings.htm | [] |
Banzai International, Inc. | [
"BNZIW"
] | 0001826011 | 7372 | 06 Technology | Services-Prepackaged Software | [
"Nasdaq"
] | S-1/A | 2020-12-15 00:00:00 | 0001213900-20-042681 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001826011/000121390020042681/ea131635-s1a1_7gcholdings.htm | [] |
Banzai International, Inc. | [
"BNZIW"
] | 0001826011 | 7372 | 06 Technology | Services-Prepackaged Software | [
"Nasdaq"
] | S-1 | 2020-12-07 00:00:00 | 0001213900-20-041190 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001826011/000121390020041190/fs12020_7gcholdings.htm | [] |
Evaxion A/S | [
"EVAX"
] | 0001828253 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | F-1 | 2025-11-21 00:00:00 | 0001104659-25-114804 | true | ABOUT THIS PROSPECTUS; SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS; PROSPECTUS SUMMARY; THE OFFERING; SUMMARY CONSOLIDATED FINANCIAL DATA; RISK FACTORS; DIVIDEND POLICY; MARKET, INDUSTRY AND OTHER DATA; USE OF PROCEEDS; CAPITALIZATION; PRIVATE PLACEMENT OF WARRANTS; SELLING SHAREHOLDER; DESCRIPTION OF SHARE CAPITAL AND ARTICLES OF ASSOCIATION; DESCRIPTION OF AMERICAN DEPOSITARY SHARES; MATERIAL INCOME TAX CONSIDERATIONS; PLAN OF DISTRIBUTION; EXPENSES OF THE OFFERING; LEGAL MATTERS; EXPERTS; WHERE YOU CAN FIND MORE INFORMATION; INFORMATION INCORPORATED BY REFERENCE | true | ./parsed_sections/prospectus_summary/2025/EVAX_evaxion-a_prospectus_summary.txt | 3 | true | ./parsed_sections/risk_factors/2025/EVAX_evaxion-a_risk_factors.txt | 1,748 | false | ./parsed_sections/legal_matters/2025/EVAX_evaxion-a_legal_matters.txt | 50 | https://www.sec.gov/Archives/edgar/data/0001828253/000110465925114804/tm2525392-1_f1.htm | [
"https://www.sec.gov/Archives/edgar/data/0001828253/000110465925114804/lg_evaxionaipowvacc-bwlr.jpg"
] |
Evaxion A/S | [
"EVAX"
] | 0001828253 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | F-1/A | 2025-01-28 00:00:00 | 0001104659-25-006720 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001828253/000110465925006720/tm2427973-7_f1a.htm | [] |
Evaxion A/S | [
"EVAX"
] | 0001828253 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | F-1/A | 2024-12-17 00:00:00 | 0001104659-24-129424 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001828253/000110465924129424/tm2427973-5_f1a.htm | [] |
Evaxion A/S | [
"EVAX"
] | 0001828253 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | F-1/A | 2024-12-05 00:00:00 | 0001104659-24-125931 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001828253/000110465924125931/tm2427973-3_f1a.htm | [] |
Evaxion A/S | [
"EVAX"
] | 0001828253 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | F-1 | 2024-11-18 00:00:00 | 0001104659-24-120159 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001828253/000110465924120159/tm2427973-1_f1.htm | [] |
Evaxion A/S | [
"EVAX"
] | 0001828253 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | F-1/A | 2024-08-20 00:00:00 | 0001104659-24-091081 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001828253/000110465924091081/tm2413457-6_f1a.htm | [] |
Evaxion A/S | [
"EVAX"
] | 0001828253 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | F-1/A | 2024-07-22 00:00:00 | 0001104659-24-081492 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001828253/000110465924081492/tm2413457-3_f1a.htm | [] |
Evaxion A/S | [
"EVAX"
] | 0001828253 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | F-1 | 2024-05-06 00:00:00 | 0001104659-24-057512 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001828253/000110465924057512/tm2413457-1_f1.htm | [] |
Evaxion A/S | [
"EVAX"
] | 0001828253 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | F-1/A | 2024-01-31 00:00:00 | 0001104659-24-008874 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001828253/000110465924008874/tm2334005-6_f1a.htm | [] |
Evaxion A/S | [
"EVAX"
] | 0001828253 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | F-1/A | 2024-01-31 00:00:00 | 0001104659-24-008585 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001828253/000110465924008585/tm2334005d7_f1a.htm | [] |
Evaxion A/S | [
"EVAX"
] | 0001828253 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | F-1/A | 2024-01-30 00:00:00 | 0001104659-24-008168 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001828253/000110465924008168/tm2334005-3_f1a.htm | [] |
Evaxion A/S | [
"EVAX"
] | 0001828253 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | F-1 | 2024-01-12 00:00:00 | 0001104659-24-003760 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001828253/000110465924003760/evax-20230930xf1.htm | [] |
Evaxion A/S | [
"EVAX"
] | 0001828253 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | F-1/A | 2022-08-22 00:00:00 | 0001104659-22-093396 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001828253/000110465922093396/tm2220308-4_f1a.htm | [] |
Evaxion A/S | [
"EVAX"
] | 0001828253 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | F-1 | 2022-07-07 00:00:00 | 0001104659-22-078077 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001828253/000110465922078077/tm2220308-1_f1.htm | [] |
Evaxion A/S | [
"EVAX"
] | 0001828253 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | F-1/A | 2021-11-03 00:00:00 | 0001104659-21-133373 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001828253/000110465921133373/tm2119736-7_f1a.htm | [] |
Evaxion A/S | [
"EVAX"
] | 0001828253 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | F-1 | 2021-10-26 00:00:00 | 0001104659-21-129737 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001828253/000110465921129737/evax-20211026xf1.htm | [] |
Evaxion A/S | [
"EVAX"
] | 0001828253 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | F-1/A | 2021-02-01 00:00:00 | 0001104659-21-010257 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001828253/000110465921010257/tm2031352-18_f1a.htm | [] |
Evaxion A/S | [
"EVAX"
] | 0001828253 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | F-1/A | 2021-01-25 00:00:00 | 0001104659-21-006826 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001828253/000110465921006826/tm2031352-15_f1a.htm | [] |
Evaxion A/S | [
"EVAX"
] | 0001828253 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | F-1/A | 2021-01-19 00:00:00 | 0001104659-21-005403 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001828253/000110465921005403/tm2031352-13_f1a.htm | [] |
Evaxion A/S | [
"EVAX"
] | 0001828253 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | F-1 | 2021-01-08 00:00:00 | 0001104659-21-002525 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001828253/000110465921002525/tm2031352-11_f1.htm | [] |
ASIAFIN HOLDINGS CORP. | [
"ASFH"
] | 0001828748 | 7389 | 07 Trade & Services | Services-Business Services, NEC | [
"OTC"
] | S-1/A | 2025-11-28 00:00:00 | 0001493152-25-025318 | true | ABOUT THIS PROSPECTUS; PRESENTATION OF FINANCIAL INFORMATION; INDUSTRY AND MARKET DATA; TRADEMARKS, SERVICE MARKETS AND TRADE NAMES; ENFORCEMENT OF CIVIL LIABILITIES; CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS; PROSPECTUS SUMMARY; RISK FACTORS; USE OF PROCEEDS; MARKET FOR OUR COMMON STOCK AND RELATED STOCKHOLDER MATTERS; DIVIDEND POLICY; CAPITALIZATION; DILUTION; MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS; BUSINESS; MANAGEMENT; EXECUTIVE AND DIRECTOR COMPENSATION; PRINCIPAL STOCKHOLDERS; RELATED PARTY TRANSACTIONS; DESCRIPTION OF OUR SECURITIES; SHARES ELIGIBLE FOR FUTURE SALE; UNDERWRITING; SELLING RESTRICTIONS; LEGAL MATTERS; EXPERTS; WHERE YOU CAN FIND ADDITIONAL INFORMATION; INDEX TO CONSOLIDATED FINANCIAL STATEMENTS | false | ./parsed_sections/prospectus_summary/2025/ASFH_asiafin_prospectus_summary.txt | 3 | true | ./parsed_sections/risk_factors/2025/ASFH_asiafin_risk_factors.txt | 13,104 | false | ./parsed_sections/legal_matters/2025/ASFH_asiafin_legal_matters.txt | 18,463 | https://www.sec.gov/Archives/edgar/data/0001828748/000149315225025318/forms-1a.htm | [
"https://www.sec.gov/Archives/edgar/data/0001828748/000149315225025318/forms-1_001.jpg",
"https://www.sec.gov/Archives/edgar/data/0001828748/000149315225025318/ba_001.jpg",
"https://www.sec.gov/Archives/edgar/data/0001828748/000149315225025318/ba_002.jpg",
"https://www.sec.gov/Archives/edgar/data/0001828748/000149315225025318/chart1_001.jpg",
"https://www.sec.gov/Archives/edgar/data/0001828748/000149315225025318/forms-1_003.jpg",
"https://www.sec.gov/Archives/edgar/data/0001828748/000149315225025318/forms-1_004.jpg",
"https://www.sec.gov/Archives/edgar/data/0001828748/000149315225025318/chart1_002.jpg",
"https://www.sec.gov/Archives/edgar/data/0001828748/000149315225025318/logo_001.jpg"
] |
ASIAFIN HOLDINGS CORP. | [
"ASFH"
] | 0001828748 | 7389 | 07 Trade & Services | Services-Business Services, NEC | [
"OTC"
] | S-1/A | 2025-11-25 00:00:00 | 0001493152-25-024877 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001828748/000149315225024877/forms-1a.htm | [] |
ASIAFIN HOLDINGS CORP. | [
"ASFH"
] | 0001828748 | 7389 | 07 Trade & Services | Services-Business Services, NEC | [
"OTC"
] | S-1 | 2025-06-16 00:00:00 | 0001641172-25-015189 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001828748/000164117225015189/forms-1.htm | [] |
ASIAFIN HOLDINGS CORP. | [
"ASFH"
] | 0001828748 | 7389 | 07 Trade & Services | Services-Business Services, NEC | [
"OTC"
] | S-1/A | 2021-03-19 00:00:00 | 0001599916-21-000041 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001828748/000159991621000041/asiafin_s1a2.htm | [] |
ASIAFIN HOLDINGS CORP. | [
"ASFH"
] | 0001828748 | 7389 | 07 Trade & Services | Services-Business Services, NEC | [
"OTC"
] | S-1/A | 2021-02-08 00:00:00 | 0001599916-21-000015 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001828748/000159991621000015/asiafin_s1a1.htm | [] |
ASIAFIN HOLDINGS CORP. | [
"ASFH"
] | 0001828748 | 7389 | 07 Trade & Services | Services-Business Services, NEC | [
"OTC"
] | S-1 | 2020-12-17 00:00:00 | 0001599916-20-000160 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001828748/000159991620000160/asiafin_s1.htm | [] |
BullFrog AI Holdings, Inc. | [
"BFRGW"
] | 0001829247 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2025-10-10 00:00:00 | 0001493152-25-017809 | true | ABOUT THIS PROSPECTUS; PROSPECTUS SUMMARY; THE OFFERING; RISK FACTORS; CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS; THE LINCOLN PARK TRANSACTION; USE OF PROCEEDS; DILUTION; SELLING STOCKHOLDER; PLAN OF DISTRIBUTION; DESCRIPTION OF SECURITIES TO BE REGISTERED; LEGAL MATTERS; EXPERTS; WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION OF DOCUMENTS BY REFERENCE | false | ./parsed_sections/prospectus_summary/2025/BFRGW_bullfrog_prospectus_summary.txt | 169 | false | ./parsed_sections/risk_factors/2025/BFRGW_bullfrog_risk_factors.txt | 7,984 | false | ./parsed_sections/legal_matters/2025/BFRGW_bullfrog_legal_matters.txt | 382 | https://www.sec.gov/Archives/edgar/data/0001829247/000149315225017809/forms-1.htm | [] |
BullFrog AI Holdings, Inc. | [
"BFRGW"
] | 0001829247 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2024-11-25 00:00:00 | 0001493152-24-047649 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001829247/000149315224047649/forms-1a.htm | [] |
BullFrog AI Holdings, Inc. | [
"BFRGW"
] | 0001829247 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2024-11-08 00:00:00 | 0001493152-24-044312 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001829247/000149315224044312/forms-1.htm | [] |
BullFrog AI Holdings, Inc. | [
"BFRGW"
] | 0001829247 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2024-01-29 00:00:00 | 0001493152-24-004069 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001829247/000149315224004069/forms-1.htm | [] |
BullFrog AI Holdings, Inc. | [
"BFRGW"
] | 0001829247 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2023-02-13 00:00:00 | 0001493152-23-004489 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001829247/000149315223004489/forms-1a.htm | [] |
BullFrog AI Holdings, Inc. | [
"BFRGW"
] | 0001829247 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2023-01-10 00:00:00 | 0001493152-23-001097 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001829247/000149315223001097/forms-1a.htm | [] |
BullFrog AI Holdings, Inc. | [
"BFRGW"
] | 0001829247 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2022-12-08 00:00:00 | 0001493152-22-034931 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001829247/000149315222034931/forms-1a.htm | [] |
BullFrog AI Holdings, Inc. | [
"BFRGW"
] | 0001829247 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2022-11-28 00:00:00 | 0001493152-22-033789 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001829247/000149315222033789/forms-1a.htm | [] |
BullFrog AI Holdings, Inc. | [
"BFRGW"
] | 0001829247 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2022-11-07 00:00:00 | 0001493152-22-030785 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001829247/000149315222030785/forms-1a.htm | [] |
BullFrog AI Holdings, Inc. | [
"BFRGW"
] | 0001829247 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2022-10-19 00:00:00 | 0001493152-22-028912 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001829247/000149315222028912/forms-1.htm | [] |
Functional Brands Inc. | [
"MEHA"
] | 0001837254 | 2833 | 03 Life Sciences | Medicinal Chemicals & Botanical Products | [
"Nasdaq"
] | S-1/A | 2025-10-16 00:00:00 | 0001213900-25-099499 | true | About this Prospectus; Prospectus Summary; Risk Factors; Cautionary Statement Regarding Forward-Looking Statements; Use of Proceeds; Dividend Policy; Capitalization; Management’s Discussion and Analysis of Financial Condition and Results of Operations; Business; Management; Executive and Director Compensation; Certain Relationships and Related Party Transactions; Principal and Registered Stockholders; Description of Securities; Shares Eligible for Future Sale; Material U.S. Federal Tax Considerations for Non-U.S. Holders of Our Common Stock; Plan of Distribution; Legal Matters; Interests of Named Experts and Counsel; Experts; Where You Can Find More Information | true | ./parsed_sections/prospectus_summary/2025/MEHA_functional_prospectus_summary.txt | 7,133 | true | ./parsed_sections/risk_factors/2025/MEHA_functional_risk_factors.txt | 44,503 | false | ./parsed_sections/legal_matters/2025/MEHA_functional_legal_matters.txt | 6,525 | https://www.sec.gov/Archives/edgar/data/0001837254/000121390025099499/ea0261519-s1a13_functional.htm | [
"https://www.sec.gov/Archives/edgar/data/0001837254/000121390025099499/image_001.jpg",
"https://www.sec.gov/Archives/edgar/data/0001837254/000121390025099499/image_002.jpg",
"https://www.sec.gov/Archives/edgar/data/0001837254/000121390025099499/image_003.jpg",
"https://www.sec.gov/Archives/edgar/data/0001837254/000121390025099499/image_004.jpg",
"https://www.sec.gov/Archives/edgar/data/0001837254/000121390025099499/image_005.jpg",
"https://www.sec.gov/Archives/edgar/data/0001837254/000121390025099499/image_006.jpg",
"https://www.sec.gov/Archives/edgar/data/0001837254/000121390025099499/image_007.jpg",
"https://www.sec.gov/Archives/edgar/data/0001837254/000121390025099499/image_008.jpg",
"https://www.sec.gov/Archives/edgar/data/0001837254/000121390025099499/image_009.jpg",
"https://www.sec.gov/Archives/edgar/data/0001837254/000121390025099499/image_010.jpg",
"https://www.sec.gov/Archives/edgar/data/0001837254/000121390025099499/image_011.jpg",
"https://www.sec.gov/Archives/edgar/data/0001837254/000121390025099499/fin_001.jpg",
"https://www.sec.gov/Archives/edgar/data/0001837254/000121390025099499/fin_002.jpg"
] |
Functional Brands Inc. | [
"MEHA"
] | 0001837254 | 2833 | 03 Life Sciences | Medicinal Chemicals & Botanical Products | [
"Nasdaq"
] | S-1/A | 2025-10-02 00:00:00 | 0001213900-25-094858 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001837254/000121390025094858/ea0259785-s1a12_function.htm | [] |
Functional Brands Inc. | [
"MEHA"
] | 0001837254 | 2833 | 03 Life Sciences | Medicinal Chemicals & Botanical Products | [
"Nasdaq"
] | S-1/A | 2025-09-19 00:00:00 | 0001213900-25-089355 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001837254/000121390025089355/ea0258014-s1a11_functional.htm | [] |
Functional Brands Inc. | [
"MEHA"
] | 0001837254 | 2833 | 03 Life Sciences | Medicinal Chemicals & Botanical Products | [
"Nasdaq"
] | S-1/A | 2025-09-04 00:00:00 | 0001213900-25-084203 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001837254/000121390025084203/ea0255590-s1a10_functional.htm | [] |
Functional Brands Inc. | [
"MEHA"
] | 0001837254 | 2833 | 03 Life Sciences | Medicinal Chemicals & Botanical Products | [
"Nasdaq"
] | S-1/A | 2025-08-12 00:00:00 | 0001213900-25-075072 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001837254/000121390025075072/ea0252553-s1a9_functional.htm | [] |
Functional Brands Inc. | [
"MEHA"
] | 0001837254 | 2833 | 03 Life Sciences | Medicinal Chemicals & Botanical Products | [
"Nasdaq"
] | S-1/A | 2025-07-15 00:00:00 | 0001213900-25-064269 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001837254/000121390025064269/ea0248498-s1a8_functional.htm | [] |
Functional Brands Inc. | [
"MEHA"
] | 0001837254 | 2833 | 03 Life Sciences | Medicinal Chemicals & Botanical Products | [
"Nasdaq"
] | S-1/A | 2025-05-30 00:00:00 | 0001213900-25-049411 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001837254/000121390025049411/ea0243367-s1a7_functional.htm | [] |
Functional Brands Inc. | [
"MEHA"
] | 0001837254 | 2833 | 03 Life Sciences | Medicinal Chemicals & Botanical Products | [
"Nasdaq"
] | S-1/A | 2025-02-14 00:00:00 | 0001213900-25-013759 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001837254/000121390025013759/ea023112801-s1a6_functional.htm | [] |
Functional Brands Inc. | [
"MEHA"
] | 0001837254 | 2833 | 03 Life Sciences | Medicinal Chemicals & Botanical Products | [
"Nasdaq"
] | S-1/A | 2025-02-13 00:00:00 | 0001213900-25-013149 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001837254/000121390025013149/ea0230941-s1a5_functional.htm | [] |
Functional Brands Inc. | [
"MEHA"
] | 0001837254 | 2833 | 03 Life Sciences | Medicinal Chemicals & Botanical Products | [
"Nasdaq"
] | S-1/A | 2025-02-12 00:00:00 | 0001213900-25-012477 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001837254/000121390025012477/ea0230757-s1a4_functional.htm | [] |
Functional Brands Inc. | [
"MEHA"
] | 0001837254 | 2833 | 03 Life Sciences | Medicinal Chemicals & Botanical Products | [
"Nasdaq"
] | S-1/A | 2025-02-11 00:00:00 | 0001213900-25-011895 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001837254/000121390025011895/ea0230602-s1a3_functional.htm | [] |
Functional Brands Inc. | [
"MEHA"
] | 0001837254 | 2833 | 03 Life Sciences | Medicinal Chemicals & Botanical Products | [
"Nasdaq"
] | S-1/A | 2025-02-10 00:00:00 | 0001213900-25-011434 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001837254/000121390025011434/ea0230317-s1a2_functional.htm | [] |
Functional Brands Inc. | [
"MEHA"
] | 0001837254 | 2833 | 03 Life Sciences | Medicinal Chemicals & Botanical Products | [
"Nasdaq"
] | S-1/A | 2025-01-28 00:00:00 | 0001213900-25-007595 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001837254/000121390025007595/ea0228312-s1a1_functional.htm | [] |
Functional Brands Inc. | [
"MEHA"
] | 0001837254 | 2833 | 03 Life Sciences | Medicinal Chemicals & Botanical Products | [
"Nasdaq"
] | S-1 | 2025-01-08 00:00:00 | 0001213900-25-002120 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001837254/000121390025002120/ea0226997-s1_functional.htm | [] |
Inspira Technologies OXY B.H.N. Ltd | [
"IINNW"
] | 0001837493 | 3841 | 08 Industrial Applications and Services | Surgical & Medical Instruments & Apparatus | [
"Nasdaq"
] | F-1 | 2025-12-22 00:00:00 | 0001213900-25-124571 | true | PROSPECTUS SUMMARY; THE OFFERING; RISK FACTORS; CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS; USE OF PROCEEDS; DIVIDEND POLICY; CAPITALIZATION; DESCRIPTION OF SHARE CAPITAL; SELLING SHAREHOLDER; PLAN OF DISTRIBUTION; EXPENSES; LEGAL MATTERS; EXPERTS; ENFORCEABILITY OF CIVIL LIABILITIES; WHERE YOU CAN FIND ADDITIONAL INFORMATION; INCORPORATION OF CERTAIN INFORMATION BY REFERENCE | true | ./parsed_sections/prospectus_summary/2025/IINNW_inspira_prospectus_summary.txt | 3 | false | ./parsed_sections/risk_factors/2024/IINNW_inspira_risk_factors.txt | 2,470 | false | ./parsed_sections/legal_matters/2025/IINNW_inspira_legal_matters.txt | 2,016 | https://www.sec.gov/Archives/edgar/data/0001837493/000121390025124571/ea0270327-f1_inspira.htm | [
"https://www.sec.gov/Archives/edgar/data/0001837493/000121390025124571/image_001.jpg"
] |
Inspira Technologies OXY B.H.N. Ltd | [
"IINNW"
] | 0001837493 | 3841 | 08 Industrial Applications and Services | Surgical & Medical Instruments & Apparatus | [
"Nasdaq"
] | F-1/A | 2024-05-20 00:00:00 | 0001213900-24-045159 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001837493/000121390024045159/ea0206537-f1a1_inspira.htm | [] |
Inspira Technologies OXY B.H.N. Ltd | [
"IINNW"
] | 0001837493 | 3841 | 08 Industrial Applications and Services | Surgical & Medical Instruments & Apparatus | [
"Nasdaq"
] | F-1 | 2024-05-09 00:00:00 | 0001213900-24-041365 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001837493/000121390024041365/ea0205650-f1_inspira.htm | [] |
Inspira Technologies OXY B.H.N. Ltd | [
"IINNW"
] | 0001837493 | 3841 | 08 Industrial Applications and Services | Surgical & Medical Instruments & Apparatus | [
"Nasdaq"
] | F-1/A | 2021-07-01 00:00:00 | 0001213900-21-035226 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001837493/000121390021035226/ea143607-f1a7_inspiratech.htm | [] |
Inspira Technologies OXY B.H.N. Ltd | [
"IINNW"
] | 0001837493 | 3841 | 08 Industrial Applications and Services | Surgical & Medical Instruments & Apparatus | [
"Nasdaq"
] | F-1/A | 2021-06-28 00:00:00 | 0001213900-21-034372 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001837493/000121390021034372/ea143325-f1a6_inspiratech.htm | [] |
Inspira Technologies OXY B.H.N. Ltd | [
"IINNW"
] | 0001837493 | 3841 | 08 Industrial Applications and Services | Surgical & Medical Instruments & Apparatus | [
"Nasdaq"
] | F-1/A | 2021-06-08 00:00:00 | 0001213900-21-031503 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001837493/000121390021031503/ea140235-f1a5_inspiratech.htm | [] |
Inspira Technologies OXY B.H.N. Ltd | [
"IINNW"
] | 0001837493 | 3841 | 08 Industrial Applications and Services | Surgical & Medical Instruments & Apparatus | [
"Nasdaq"
] | F-1/A | 2021-03-31 00:00:00 | 0001213900-21-018951 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001837493/000121390021018951/ea138700-f1a4_inspiratech.htm | [] |
Inspira Technologies OXY B.H.N. Ltd | [
"IINNW"
] | 0001837493 | 3841 | 08 Industrial Applications and Services | Surgical & Medical Instruments & Apparatus | [
"Nasdaq"
] | F-1/A | 2021-03-29 00:00:00 | 0001213900-21-018361 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001837493/000121390021018361/ea138535-f1a3_inspiratech.htm | [] |
Inspira Technologies OXY B.H.N. Ltd | [
"IINNW"
] | 0001837493 | 3841 | 08 Industrial Applications and Services | Surgical & Medical Instruments & Apparatus | [
"Nasdaq"
] | F-1/A | 2021-03-22 00:00:00 | 0001213900-21-016846 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001837493/000121390021016846/ea138125-f1a2_inspiratech.htm | [] |
Inspira Technologies OXY B.H.N. Ltd | [
"IINNW"
] | 0001837493 | 3841 | 08 Industrial Applications and Services | Surgical & Medical Instruments & Apparatus | [
"Nasdaq"
] | F-1/A | 2021-03-12 00:00:00 | 0001213900-21-015150 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001837493/000121390021015150/ea137365-f1a1_inspiratech.htm | [] |
Inspira Technologies OXY B.H.N. Ltd | [
"IINNW"
] | 0001837493 | 3841 | 08 Industrial Applications and Services | Surgical & Medical Instruments & Apparatus | [
"Nasdaq"
] | F-1 | 2021-03-05 00:00:00 | 0001213900-21-013704 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001837493/000121390021013704/ea137084-f1_inspiratech.htm | [] |
Encore Medical, Inc. | [
"EMI"
] | 0001838003 | 3841 | 08 Industrial Applications and Services | Surgical & Medical Instruments & Apparatus | [] | S-1/A | 2025-12-30 00:00:00 | 0001104659-25-125214 | true | CONVENTIONS AND ASSUMPTIONS USED IN THIS PROSPECTUS; INDUSTRY AND MARKET DATA; PROSPECTUS SUMMARY; RISK FACTORS; CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS; USE OF PROCEEDS; DIVIDEND POLICY; CAPITALIZATION; SERIES A PREFERRED STOCK CONVERSION; DILUTION; MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS; BUSINESS; MANAGEMENT; EXECUTIVE COMPENSATION; PRINCIPAL SHAREHOLDERS; DESCRIPTION OF SECURITIES; SHARES ELIGIBLE FOR FUTURE SALE; PLAN OF DISTRIBUTION; MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS FOR NON-U.S. HOLDERS OF COMMON STOCK; LEGAL MATTERS; EXPERTS; WHERE YOU CAN FIND MORE INFORMATION; Index to Financial Statements | false | ./parsed_sections/prospectus_summary/2025/EMI_encore_prospectus_summary.txt | 3 | false | ./parsed_sections/risk_factors/2025/EMI_encore_risk_factors.txt | 9,236 | true | ./parsed_sections/legal_matters/2025/EMI_encore_legal_matters.txt | 58 | https://www.sec.gov/Archives/edgar/data/0001838003/000110465925125214/tm2525595-3_s1.htm | [
"https://www.sec.gov/Archives/edgar/data/0001838003/000110465925125214/lg_emi-4c.jpg",
"https://www.sec.gov/Archives/edgar/data/0001838003/000110465925125214/lg_encoremedical-4c.jpg",
"https://www.sec.gov/Archives/edgar/data/0001838003/000110465925125214/ph_pfoproduct01-4clr.jpg",
"https://www.sec.gov/Archives/edgar/data/0001838003/000110465925125214/ph_pfoproduct02-4clr.jpg",
"https://www.sec.gov/Archives/edgar/data/0001838003/000110465925125214/ph_pfoproduct03-4clr.jpg",
"https://www.sec.gov/Archives/edgar/data/0001838003/000110465925125214/lg_boulay-4c.jpg",
"https://www.sec.gov/Archives/edgar/data/0001838003/000110465925125214/sg_boulaypllp-bw.jpg"
] |
Encore Medical, Inc. | [
"EMI"
] | 0001838003 | 3841 | 08 Industrial Applications and Services | Surgical & Medical Instruments & Apparatus | [] | S-1 | 2025-09-15 00:00:00 | 0001104659-25-089675 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001838003/000110465925089675/tm2525595-1_s1.htm | [] |
Revium Rx. | [
"RVRC"
] | 0001839140 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"OTC"
] | S-1/A | 2026-01-28 00:00:00 | 0001213900-26-008804 | true | null | false | null | 0 | false | ./parsed_sections/risk_factors/2025/RVRC_revium-rx_risk_factors.txt | 80,255 | false | null | 0 | https://www.sec.gov/Archives/edgar/data/0001839140/000121390026008804/ea0274442-s1a5_revium.htm | [] |
Revium Rx. | [
"RVRC"
] | 0001839140 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"OTC"
] | S-1/A | 2026-01-16 00:00:00 | 0001213900-26-005242 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001839140/000121390026005242/ea0272700-s1a4_revium.htm | [] |
Revium Rx. | [
"RVRC"
] | 0001839140 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"OTC"
] | S-1/A | 2025-12-12 00:00:00 | 0001213900-25-121070 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001839140/000121390025121070/ea0268034-s1a3_revium.htm | [] |
Revium Rx. | [
"RVRC"
] | 0001839140 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"OTC"
] | S-1/A | 2025-10-03 00:00:00 | 0001213900-25-096094 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001839140/000121390025096094/ea0259119-s1a2_revium.htm | [] |
Revium Rx. | [
"RVRC"
] | 0001839140 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"OTC"
] | S-1/A | 2025-08-13 00:00:00 | 0001213900-25-075747 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001839140/000121390025075747/ea0251490-s1a1_revium.htm | [] |
Revium Rx. | [
"RVRC"
] | 0001839140 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"OTC"
] | S-1 | 2025-02-14 00:00:00 | 0001213900-25-013823 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001839140/000121390025013823/ea0230667-s1_revium.htm | [] |
SPECIFICITY, INC. | [
"SPTY"
] | 0001840102 | 7311 | 07 Trade & Services | Services-Advertising Agencies | [
"OTC"
] | S-1 | 2025-10-14 00:00:00 | 0001520138-25-000306 | true | PROSPECTUS SUMMARY; SUMMARY FINANCIAL INFORMATION; SUMMARY OF THIS OFFERING; RISK FACTORS; USE OF PROCEEDS; DETERMINATION OF OFFERING PRICE; PLAN OF DISTRIBUTION; TERMS OF THE OFFERING; DESCRIPTION OF SECURITIES; INTERESTS OF NAMED EXPERTS AND COUNSEL; INFORMATION WITH RESPECT TO REGISTRANT; DESCRIPTION OF BUSINESS; DESCRIPTION OF PROPERTY; LEGAL PROCEEDINGS; MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTER; DIVIDEND POLICY; SELECTED FINANCIAL DATA AND MANAGEMENT’S DISCUSSION AND ANALYSIS; CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE; QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK; DIRECTORS AND EXECUTIVE OFFICERS; EXECUTIVE COMPENSATION AND CORPORATE GOVERNANCE; SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT; CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS; LEGAL MATTERS; EXPERTS; COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES; WHERE YOU CAN FIND MORE INFORMATION; INDEX TO FINANCIAL STATEMENTS | false | ./parsed_sections/prospectus_summary/2025/SPTY_specificit_prospectus_summary.txt | 3 | true | ./parsed_sections/risk_factors/2025/SPTY_specificit_risk_factors.txt | 7,484 | false | ./parsed_sections/legal_matters/2025/SPTY_specificit_legal_matters.txt | 2,127 | https://www.sec.gov/Archives/edgar/data/0001840102/000152013825000306/spec-10102025_s1.htm | [] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.